[1]
T. M. Bonde, “Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists”, SJU, vol. 56, no. 3, pp. 169–175, May 2022.